Kane Biotech Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was CAD 0.565433 million compared to CAD 0.376039 million a year ago. Net loss was CAD 1.11 million compared to CAD 0.908467 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.